Study of etrasimod for active ulcerative colitis
Treatments studied
Part of Digestive system clinical trials.
This study is looking at how well etrasimod works for people with active ulcerative colitis. If you are already taking etrasimod and started it within the last 6 months, you may be able to join and help researchers learn more about its benefits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have active ulcerative colitis (UC) with symptoms like frequent bowel movements or rectal bleeding, or a recent scope showing inflammation.
- You have been taking etrasimod for no more than 6 months.
- You have not already tried 3 or more biologic therapies, or 2 biologics plus a JAK inhibitor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medicines — etrasimod (a new pill) and mesalazine (a standard anti-inflammatory) — to see which works better and is safer for Chinese adults with active ulcerative colitis. Participants will receive one of the two treatments, and the study aims to find if the newer drug offers more benefit.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
This study tests a new drug called XmAb942 for people with moderate to severe ulcerative colitis. It aims to see if the drug can reduce inflammation and improve symptoms when other treatments haven't worked well enough or caused side effects.
This study tests an investigational medication called LY4268989 for adults with moderate to severe ulcerative colitis (UC). It's for people who have tried other treatments without success. The goal is to see if the drug can reduce inflammation and improve symptoms.
This study watches how well etrasimod works for adults with moderate to severe ulcerative colitis (UC). You must already be prescribed etrasimod by your doctor, and the study collects information through a web-based tool.
This trial tests if the medicine etrasimod can help children with moderate to severe ulcerative colitis. You may still be able to join even if you are already taking other treatments for your condition.
Hear when a new Ulcerative Colitis (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.